After scrapping a Biden-era plan to cover obesity drugs in early 2025, the Trump administration reversed course: it struck deals with Novo Nordisk and Eli Lilly in November 2025 to cut GLP-1 prices, and a voluntary Medicare demonstration begins July 1, 2026 that lets participating drug plans cover GLP-1s for weight loss with a $50 monthly copay
Its a dermatologist-approved, antioxidant-driven, clinical glow-upand when done right, it can make a visible difference
At LIVGLAM, we provide customized care with FDA-approved formulations under the expert guidance of Dr
Our medical team will design a tailored protocol to support fat metabolism, body composition, and long-term metabolic health through safe, science-backed care.
Many people feel more alert and less fatigued after treatment, which can make it easier to stick to an exercise routine